As the world nears eradicating polio, Nigeria stands as one of the few countries that remain polio endemic.
The world is anxious for a dengue vaccine. It is estimated that 40 percent of the global population is at risk, and in too many countries, dengue fever is common and frequently causes outbreaks.
As the campaigns start looking to win over every vote in the pivotal swing states, it may be worth examining more closely the local links between global health and jobs, and the opportunity to tap into an issue that could energize university students.
Nigeria is home to one out of every eight child deaths worldwide, and the Decade of Vaccines Economics projects 90 percent vaccine coverage can save 600,000 lives and $17 billion in Nigeria over the next 10 years.
Likewise, as one of only three remaining countries in the world with endemic polio transmission, they have recently ramped up efforts to eradicate polio from the country, and thereby, help rid it from the entire world.
Finding the right balance between affordable prices, innovation, and supply security will require hard work, patience, and a long-term view.
With the expanded use of life-saving interventions like the pneumococcal vaccine, we need to learn as much as possible about the remaining causes of severe pneumonia in children as we can.
In 1986, as a sophomore at Gettysburg College, I accompanied my dad, a pediatrician and vaccine researcher, on a two-week trip to Rwanda. I was insta...
The rewards of a career in public health are infrequent and often hard to see. In clinical medicine, doctors and nurses have the benefit of experiencing the impact they have on people's lives on a daily basis.
In the past two decades, the international donor community has ushered in a historic expansion of global health programs. Through multi-country initi...
At the World Economic Forum this year, Bill Gates announced the Decade of Vaccines with a $10 billion commitment from his Foundation to support its a...
Stopping meningitis epidemics makes good sense on many levels -- health, economic, and humanitarian among them. We need to approach this issue from a different angle: one of self-interest.
Only in its second year, it seems like World Pneumonia Day might be moving from spark to blaze -- engaging governments, child health organizations and advocates in an effort to spotlight the leading killer of children.
A quick Google News search this morning using the term "pneumonia" brought up a bunch of stories. Most of them were about Canadian folk singer Bruce C...
This blog entry is authored by Toy McGee, one of Orin Levine's graduate students at the Johns Hopkins Bloomberg School of Public Health. This post is ...
Want a sneak peak at the future of global health? One way is to find out what's on the minds of the next generation of policy leaders and influencers.
Access to life-saving vaccines should not be determined by the lottery of birthplace and every child deserves a healthy future, whether they are born in Baltimore or Bangalore.
I wish that I were the leader of a G-8 country this week. There are two reasons. First, the G-8 is meeting in Huntsville, Ontario, one of my favor...
This coming Saturday its World Meningitis Day. This Sunday is World Malaria Day. When I first heard that these two were occurring so close toget...
Could getting rid of a case of wine help get rid of cases of pneumonia? This is the idea that came to me last week when New York Times wine criti...
These days it seems that everyone around me knows a family member, friend, neighbor, or congregation member who has battled breast cancer. Some c...
Today, the world's ministers of health deserve our praise and recognition for resolving themselves to tackle the biggest killer of children with pr...
All too often it seems like the good guys get left behind, while the not-so-good guys get the recognition. So I'm pleased to say that today there's r...
On its 10th anniversary, it is easy to appreciate the accomplishments of the GAVI Alliance, whose work has led to immunizations that will avert four million deaths in the developing world.
The long-term answer to sustainable vaccine access for developing countries is structuring pricing to make doses affordable to those countries.
